Variations in Medicare Advantage Switching Rates Among African American and Hispanic Medicare Beneficiaries With Alzheimer's Disease and Related Dementias, by Sex and Dual Eligibility

被引:3
|
作者
Rivera-Hernandez, Maricruz [1 ,2 ]
Meyers, David J. [1 ,2 ]
Kim, Daeho [1 ,2 ]
Park, Sungchul [3 ,4 ]
Trivedi, Amal N. [1 ,2 ]
机构
[1] Brown Univ, Sch Publ Hlth, Dept Hlth Serv Policy & Practice, Providence, RI 02912 USA
[2] Brown Univ, Ctr Gerontol & Healthcare Res, Sch Publ Hlth, Providence, RI 02912 USA
[3] Korea Univ, Coll Hlth Sci, Dept Hlth Policy & Management, Seoul, South Korea
[4] Korea Univ, BK21 Four R&E Ctr Learning Hlth Syst, Seoul, South Korea
基金
美国国家卫生研究院;
关键词
Dementia; Health care costs; Health insurance; Racial disparities;
D O I
10.1093/geronb/gbac132
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Objectives The objective of this study was to identify rates of switching to Medicare Advantage (MA) among fee-for-service (FFS) Medicare beneficiaries with Alzheimer's disease and related dementias (ADRD) by race/ethnicity and whether these rates vary by sex and dual-eligibility status for Medicare and Medicaid. Methods Data came from the Medicare Master Beneficiary Summary File from 2017 to 2018. The outcome of interest for this study was switching from FFS to MA during any month in 2018. The primary independent variable was race/ethnicity including non-Hispanic White, non-Hispanic African American, and Hispanic beneficiaries. Two interaction terms among race/ethnicity and dual eligibility, and race/ethnicity and sex were included. The model adjusted for age, year of ADRD diagnosis, the number of chronic/disabling conditions, total health care costs, and ZIP code fixed effects. Results The study included 2,284,175 FFS Medicare beneficiaries with an ADRD diagnosis in 2017. Among dual-eligible beneficiaries, adjusted rates of switching were higher among African American (1.91 percentage points [p.p.], 95% confidence interval [CI]: 1.68-2.15) and Hispanic beneficiaries (1.36 p.p., 95% CI: 1.07-1.64) compared to non-Hispanic White beneficiaries. Among males, adjusted rates were higher among African American (3.28 p.p., 95% CI: 2.97-3.59) and Hispanic beneficiaries (2.14 p.p., 95% CI: 1.86-2.41) compared to non-Hispanic White beneficiaries. Discussion Among persons with ADRD, African American and Hispanic beneficiaries are more likely than White beneficiaries to switch from FFS to MA. This finding underscores the need to monitor the quality and equity of access and care for these populations.
引用
收藏
页码:E279 / E287
页数:9
相关论文
共 50 条
  • [1] Plan switching among Medicare Advantage beneficiaries with Alzheimer's disease and other dementias
    Meyers, David J.
    Rahman, Momotazur
    Rivera-Hernandez, Maricruz
    Trivedi, Amal N.
    Mor, Vincent
    ALZHEIMERS & DEMENTIA-TRANSLATIONAL RESEARCH & CLINICAL INTERVENTIONS, 2021, 7 (01)
  • [2] Comparing the care experiences of Medicare Advantage beneficiaries with and without Alzheimer's disease and related dementias
    Meyers, David J.
    Rivera-Hernandez, Maricruz
    Kim, Daeho
    Keohane, Laura M.
    Mor, Vincent
    Trivedi, Amal N.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2022, 70 (08) : 2344 - 2353
  • [3] Risk Adjustment for Medicare Beneficiaries With Alzheimer's Disease and Related Dementias
    Lin, Pei-Jung
    Maciejewski, Matthew L.
    Paul, John E.
    Biddle, Andrea K.
    AMERICAN JOURNAL OF MANAGED CARE, 2010, 16 (03): : 191 - 198
  • [4] Disparities in Nursing Home Use and Quality Among African American, Hispanic, and White Medicare Residents With Alzheimer's Disease and Related Dementias
    Rivera-Hernandez, Maricruz
    Kumar, Amit
    Epstein-Lubow, Gary
    Thomas, Kali S.
    JOURNAL OF AGING AND HEALTH, 2019, 31 (07) : 1259 - 1277
  • [5] Medicare Advantage Enrollment and Disenrollment Among Persons With Alzheimer Disease and Related Dementias
    James, Hannah O.
    Trivedi, Amal N.
    Meyers, David J.
    JAMA HEALTH FORUM, 2023, 4 (09): : E233080
  • [6] Implications of Medicare Advantage for Patients With Alzheimer Disease and Related Dementias
    Dosa, David M.
    Trivedi, Amal N.
    Mor, Vincent
    JAMA NETWORK OPEN, 2020, 3 (03)
  • [7] Healthcare utilization of Mexican-American Medicare beneficiaries with and without Alzheimer's disease and related dementias
    Downer, Brian
    Al Snih, Soham
    Raji, Mukaila
    Chou, Lin-Na
    Kuo, Yong-Fang
    Markides, Kyriakos S.
    Ottenbacher, Kenneth J.
    PLOS ONE, 2020, 15 (01):
  • [8] Diagnosed prevalence of Alzheimer's disease and related dementias in Medicare Advantage plans
    Jutkowitz, Eric
    Bynum, Julie P. W.
    Mitchell, Susan L.
    Cocoros, Noelle M.
    Shapira, Oren
    Haynes, Kevin
    Nair, Vinit P.
    McMahill-Walraven, Cheryl N.
    Platt, Richard
    McCarthy, Ellen P.
    ALZHEIMER'S & DEMENTIA: DIAGNOSIS, ASSESSMENT & DISEASE MONITORING, 2020, 12 (01)
  • [9] TRENDS IN OSTEOPOROSIS DRUG USE AMONG MEDICARE BENEFICIARIES WITH & WITHOUT ALZHEIMER'S DISEASE/RELATED DEMENTIAS
    Armstrong, Peyton
    Kuo, Yong-Fang
    Westra, Jordan
    Raji, Mukaila
    INNOVATION IN AGING, 2022, 6 : 768 - 768
  • [10] Trends in observation stays for Medicare beneficiaries with and without Alzheimer's disease and related dementias
    Burke, Laura G.
    Burke, Ryan C.
    Duggan, Ciara E.
    Figueroa, Jose F.
    Boltz, Marie
    Fick, Donna M.
    Orav, E. John
    Marcantonio, Edward R.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2024, 72 (05) : 1442 - 1452